STOCK TITAN
  1. Home
  2. Sec-filings
  3. NTRA
  4. [Form 4] Natera, Inc. Insider Trading Activity

Natera, Inc. (NASDAQ: NTRA) co-founder reports 4,650-share sale under 10b5-1 plans

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Natera, Inc. co-founder and director Sheena Jonathan reported 13 sales totaling 4,650 shares of Natera common stock on May 8 and May 13, 2026, at weighted-average prices between $199.00 and $210.3450 per share, effected under Rule 10b5-1 trading plans. After these trades, she holds 252,502 shares directly, with 19,532 shares held by Caraluna 1 Trust and 19,532 shares by Caraluna 2 Trust; the trust shares are held for beneficiaries, and Jonathan disclaims beneficial ownership of those securities.

Positive

  • None.

Negative

  • None.
Insider Sheena Jonathan
Role Director
Sold 4,650 shs ($959K)
Type Security Shares Price Value
Sale Common Stock 85 $199.5174 $17K
Sale Common Stock 345 $201.1139 $69K
Sale Common Stock 290 $202.5823 $59K
Sale Common Stock 30 $202.84 $6K
Sale Common Stock 96 $199.4346 $19K
Sale Common Stock 360 $201.1923 $72K
Sale Common Stock 285 $202.6829 $58K
Sale Common Stock 9 $203.295 $2K
Sale Common Stock 200 $205.43 $41K
Sale Common Stock 900 $207.2411 $187K
Sale Common Stock 700 $208.1286 $146K
Sale Common Stock 200 $209.5725 $42K
Sale Common Stock 1,150 $210.345 $242K
Holdings After Transaction: Common Stock — 252,502 shares (Direct); Common Stock — 19,532 shares (Indirect, By Caraluna 1 Trust); Common Stock — 19,532 shares (Indirect, By Caraluna 2 Trust)
Footnotes (14)
  1. F1. The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
  2. F2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $205.00 to $205.86 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. F3. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $206.52 to $207.51 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. F4. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $207.55 to $208.50 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  5. F5. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $209.2250 to $209.9200 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  6. F6. The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 7, 2024.
  7. F7. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $199.00 to $199.8950 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  8. F8. Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
  9. F9. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $200.81 to $201.74 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  10. F10. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $201.83 to $202.75 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  11. F11. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $202.83 to $202.85 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  12. F12. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $199.00 to $199.8950 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  13. F13. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $200.81 to $201.75 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  14. F14. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $201.9750 to $202.85 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Shares sold 4,650 shares Total common shares sold across 13 transactions reported
Number of sale transactions 13 transactions Open-market or private sales on May 8 and May 13, 2026
Lowest reported sale price $199.00 per share Lower bound of weighted-average price ranges in footnotes
Highest reported sale price $210.3450 per share Highest individual weighted-average sale price reported
Direct holdings after transaction 252,502 shares Common stock held directly by Sheena Jonathan post-trade
Caraluna 1 Trust holdings 19,532 shares Indirect common stock position held by Caraluna 1 Trust
Caraluna 2 Trust holdings 19,532 shares Indirect common stock position held by Caraluna 2 Trust
Rule 10b5-1 trading plan regulatory
"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The reported price in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
beneficial ownership regulatory
"The Reporting Person disclaims beneficial ownership over such securities."
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
indirect ownership financial
"ownership_type>indirect</ownership_type>"
open market or private transaction financial
"Sale in open market or private transaction"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →

FAQ

What insider activity did NTRA co-founder Sheena Jonathan report in this Form 4?
Sheena Jonathan reported 13 sales totaling 4,650 shares of Natera (NTRA) common stock on May 8 and May 13, 2026, at weighted-average prices between $199.00 and $210.3450 per share, all executed as open-market or private transactions.

How many NTRA shares does Sheena Jonathan hold after these reported transactions?
Following the reported sales, Sheena Jonathan holds 252,502 NTRA shares directly, plus 19,532 shares in Caraluna 1 Trust and 19,532 shares in Caraluna 2 Trust. The trust-held shares are for beneficiaries, and she disclaims beneficial ownership of those securities.

Were the NTRA insider sales by Sheena Jonathan made under Rule 10b5-1 trading plans?
Yes. The filing affirms Rule 10b5-1 status and footnotes state the sales were effected under Rule 10b5-1 trading plans adopted on June 7, 2024 and December 12, 2025, indicating the transactions were executed pursuant to pre-established trading instructions.

At what prices were the NTRA shares sold in Sheena Jonathan’s Form 4 filing?
The reported prices are weighted averages for multiple trades, with transactions occurring in ranges from $199.00 to $210.3450 per share. Footnotes note specific sub-ranges and confirm the holder will provide detailed trade-by-trade pricing information upon written request.

What is the role of the Caraluna trusts in Sheena Jonathan’s NTRA holdings?
Some reported NTRA shares are held indirectly by Caraluna 1 Trust and Caraluna 2 Trust, each holding 19,532 shares. A footnote states these are held for trust beneficiaries and that Sheena Jonathan disclaims beneficial ownership of the securities held in the trusts.

How many NTRA shares were sold in total in this Form 4, and over what dates?
The Form 4 reports 4,650 NTRA shares sold across 13 transactions. These sales occurred on May 8, 2026 and May 13, 2026, including both direct sales and sales by the Caraluna 1 and Caraluna 2 Trusts associated with Jonathan.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Sheena Jonathan
(Last)(First)(Middle)
C/O NATERA, INC.
13011 MCCALLEN PASS BUILDING A SUITE 100
(Street)
AUSTIN TEXAS 78753
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Natera, Inc. [ NTRA ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)XOther (specify below)
CO-FOUNDER
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/08/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/08/2026S200(1)D$205.43(2)255,452D
Common Stock05/08/2026S900(1)D$207.2411(3)254,552D
Common Stock05/08/2026S700(1)D$208.1286(4)253,852D
Common Stock05/08/2026S200(1)D$209.5725(5)253,652D
Common Stock05/08/2026S1,150(1)D$210.345252,502D
Common Stock05/13/2026S85(6)D$199.5174(7)20,197IBy Caraluna 1 Trust(8)
Common Stock05/13/2026S345(6)D$201.1139(9)19,852IBy Caraluna 1 Trust(8)
Common Stock05/13/2026S290(6)D$202.5823(10)19,562IBy Caraluna 1 Trust(8)
Common Stock05/13/2026S30(6)D$202.84(11)19,532IBy Caraluna 1 Trust(8)
Common Stock05/13/2026S96(6)D$199.4346(12)20,186IBy Caraluna 2 Trust(8)
Common Stock05/13/2026S360(6)D$201.1923(13)19,826IBy Caraluna 2 Trust(8)
Common Stock05/13/2026S285(6)D$202.6829(14)19,541IBy Caraluna 2 Trust(8)
Common Stock05/13/2026S9(6)D$203.29519,532IBy Caraluna 2 Trust(8)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $205.00 to $205.86 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $206.52 to $207.51 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
4. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $207.55 to $208.50 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
5. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $209.2250 to $209.9200 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
6. The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 7, 2024.
7. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $199.00 to $199.8950 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
8. Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
9. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $200.81 to $201.74 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
10. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $201.83 to $202.75 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
11. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $202.83 to $202.85 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
12. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $199.00 to $199.8950 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
13. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $200.81 to $201.75 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
14. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $201.9750 to $202.85 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ Tami Chen, Attorney-in-Fact05/15/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR